Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2002
10/03/2002US20020142372 Fragments of cr1 and their use
10/03/2002US20020142358 Antibody for use in the diagnosis, prevention and treatment of infections, multiple sclerosis, arthritis, autoimmune, inflammation and graft versus host disease
10/03/2002US20020142292 Mammalian genes; related reagents and methods
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142025 Mixture of proteins, carbohydrates, methionine, cysteine, folic acid, pyridoxal and zinc
10/03/2002US20020142012 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/03/2002US20020142007 Intracellular delivery vehicles
10/03/2002US20020142000 Genetic engineering
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141989 Antiinflammatory agents; antiallergens
10/03/2002US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002US20020141983 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141971 Administering by tissue absorption
10/03/2002US20020141970 Stabilized with chelate compound; storage stability
10/03/2002US20020141945 Characteristic glass transition temperature (Tg) and a recommended storage temperature (Ts), glassy matrix and drug within the glassy matrix; unit dosage; stable dispersion over time
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441933A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002CA2441893A1 Method of attenuating reactions to skin irritants
10/03/2002CA2441824A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses
10/03/2002CA2441806A1 Inosine compounds and their use for treating or preventing an inflammation or a reperfusion disease
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441663A1 Viral vectors and their use in therapeutic methods
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441588A1 Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2438206A1 Transporters and ion channels
10/03/2002CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002CA2425862A1 Cd19-specific redirected immune cells
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245567A1 HIV inhibiting pyrimidine derivatives
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245235A2 Method for extracting oleaginous substances from ganoderma lucidum spores
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244668A1 Purine derivatives, process for their preparation and use thereof
10/02/2002EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244468A2 Selective activation of a th1 or th2 lymphocyte regulated immune response
10/02/2002EP1244466A2 Activation and inhibition of the immune system
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244442A1 Method for detecting nucleotide synthesis inhibitors having fewer side effects
10/02/2002EP1244440A1 Agonists specific for the peripheral cannabinoid receptor
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP0989851B1 Self-emulsifying formulation for acidic lipophilic compounds
10/02/2002EP0906279B1 Pyrrole derivatives
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002EP0691988B1 Inhibitor of stem cell proliferation and uses thereof
10/02/2002EP0600930B1 Diagnosis and treatment of autoimmune diseases
10/02/2002DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility
10/02/2002DE10113284A1 Adjuvans-Emulsion und Verfahren zu deren Verwendung Adjuvant emulsion, and methods of use thereof
10/02/2002DE10112926A1 Use of sugar phosphate or aminoacid having e.g. transaminase inhibiting activity, for treating tumors and/or sepsis or inducing immunosuppression
10/02/2002DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002DE10112617A1 Verwendung eines C1-Esterase-Inhibitors zur Verhinderung oder Verzögerung der Abstoßung von Xenotransplantaten in Säugetieren Use of a C1-esterase inhibitor to prevent or delay the rejection of xenotransplants in mammals
10/02/2002CN1372594A OX2 receptor homologs
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372567A Method for isolating and purifying grass pollen allergens
10/02/2002CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002CN1372471A Treatment of allergic rhinitis
10/02/2002CN1372469A Immunopotentiator
10/02/2002CN1371749A Biological therapy adjuvant originated from animal Chinese medicine
10/02/2002CN1371709A Medicine for curing purpura
10/02/2002CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof
10/02/2002CN1371684A Novel biological activity of proglumide
10/02/2002CN1371680A Coculine osmosis pump type release-controlled preparation and preparation process thereof
10/02/2002CN1091603C Biological health article with immunity regulating function
10/02/2002CN1091599C Anti-HIV triple combination
1 ... 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 ... 1172